Among pediatric patients with intermittent asthma, around one-third did not have significant acute care needs over a 2-year period and dispensed two or fewer albuterol inhalers per year, according to ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

Among women who never used oral contraceptives or female hormone therapy, no significant link was found between menopause and the odds for asthma, according to data published in The Journal of Allergy ...

M Indians suffer from asthma—13% of global cases. Mortality is far higher than average due to late diagnosis, outdated care, and overuse of “blue” inhalers; ICS–formoterol is safer and preferred.

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for people with asthma, not least of all to have “zero tolerance for asthma ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.

The report updates the AAP’s 2010 guidance and emphasizes a proactive role for pediatricians in collaborating to manage student food allergies.

Discover groundbreaking discussions at the European Respiratory Society Congress 2025, focusing on severe asthma, e-cigarette debates, and global health equity in respiratory care.